Table 3 Heart valve involvement in Staphylococcus aureus endocarditis
Hemodialysis (n = 121) | Non-ESKD (n = 190) | Total (n = 311) | |
|---|---|---|---|
Mitral valve | 62 (51.2%) | 50 (26.3%) | 112 (36%) |
Aortic valve | 27 (22.3%) | 72 (37.9%) | 99 (31.8%) |
Tricuspid valve | 3 (2.5%) | 13 (6.8%) | 16 (5.1%) |
Pulmonic valve | – | 1 (0.5%) | 1 (0.3%) |
Aortic- and mitral valve | 3 (2.5%) | 25 (13.2%) | 28 (9%) |
Aortic- and tricuspid valve | – | 1 (0.5%) | 1 (0.3%) |
Aortic- and pulmonic valve | – | 1 (0.5%) | 1 (0.3%) |
Mitral- and tricuspid valve | 3 (2.5%) | 1 (0.5%) | 4 (1.3%) |
Mitral- and pulmonic valve | – | 2 (1.1%) | 2 (0.6%) |
Cardiac device lead | 5 (4.1%) | 22 (11.6%) | 27 (8.7%) |
Right side | 9 (7.4%) | 2 (1.1%) | 11 (3.5%) |
Unavailable | 9 (7.4%) | – | 9 (2.9%) |